Cargando…

Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy

Development of nano-sized carriers including nanoparticles, nanoemulsions or liposomes holds great potential for advanced delivery systems for cancer immunotherapy, as such nanostructures can be used to more effectively manipulate or deliver immunologically active components to specific target sites...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Yeong-Min, Lee, Seung Jun, Kim, Young Seob, Lee, Moon Hee, Cha, Gil Sun, Jung, In Duk, Kang, Tae Heung, Han, Hee Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817298/ https://www.ncbi.nlm.nih.gov/pubmed/24198742 http://dx.doi.org/10.4110/in.2013.13.5.177

Ejemplares similares

Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy
por: Han, Hee Dong, et al.
Publicado: (2016)

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine
por: Park, Hyun Jin, et al.
Publicado: (2019)

In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy
por: Han, Hee Dong, et al.
Publicado: (2016)

A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy
por: Lee, Seung Jun, et al.
Publicado: (2014)

Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
por: Kim, Ga Hee, et al.
Publicado: (2018)

Repositioning of the antipsychotic drug TFP for sepsis treatment
por: Park, Jung Hwa, et al.
Publicado: (2019)

Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
por: Kang, Tae Heung, et al.
Publicado: (2015)

Neoagarohexaose-mediated activation of dendritic cells via Toll-like receptor 4 leads to stimulation of natural killer cells and enhancement of antitumor immunity
por: Lee, Moon Hee, et al.
Publicado: (2017)

Mycobacterium abscessus MAB2560 induces maturation of dendritic cells via Toll-like receptor 4 and drives Th1 immune response
por: Lee, Su Jung, et al.
Publicado: (2014)

Engineered Human Ferritin Nanoparticles for Direct Delivery of Tumor Antigens to Lymph Node and Cancer Immunotherapy
por: Lee, Bo-Ram, et al.
Publicado: (2016)

Interactions between tumor-derived proteins and Toll-like receptors
por: Jang, Gun-Young, et al.
Publicado: (2020)

KAAACI Guidelines for Allergen Immunotherapy
por: Lee, Hwa Young, et al.
Publicado: (2023)

Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
por: Fan, Yuchen, et al.
Publicado: (2015)

Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches
por: Won, Ji Eun, et al.
Publicado: (2022)

Mycobacterium abscessus ᴅ-alanyl-ᴅ-alanine dipeptidase induces the maturation of dendritic cells and promotes Th1-biased immunity
por: Lee, Seung Jun, et al.
Publicado: (2016)

Interactions of Nanoparticles with Macrophages and Feasibility of Drug Delivery for Asthma
por: Kang, Sung Hun, et al.
Publicado: (2022)

Enhancement of paclitaxel-induced breast cancer cell death via the glycogen synthase kinase-3β-mediated B-cell lymphoma 2 regulation
por: Noh, Kyung Tae, et al.
Publicado: (2016)

Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy
por: Lee, Ji-Ho, et al.
Publicado: (2019)

GM-CSF-loaded chitosan hydrogel as an immunoadjuvant enhances antigen-specific immune responses with reduced toxicity
por: Noh, Kyung Hee, et al.
Publicado: (2014)

All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy
por: Song, Sukyung, et al.
Publicado: (2023)

Development of Bispecific Antibody for Cancer Immunotherapy: Focus on T Cell Engaging Antibody
por: Moon, Dain, et al.
Publicado: (2022)

The Mycobacterium avium subsp. Paratuberculosis protein MAP1305 modulates dendritic cell-mediated T cell proliferation through Toll-like receptor-4
por: Lee, Su Jung, et al.
Publicado: (2014)

Delivery Routes for COVID-19 Vaccines
por: Park, Jang Hyun, et al.
Publicado: (2021)

Application of chitosan-ZnO nanoparticle edible coating to wild-simulated Korean ginseng root
por: Kang, Soo Hyun, et al.
Publicado: (2022)

Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy
por: Lim, Seungho, et al.
Publicado: (2019)

Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel
por: Kim, Dong-Hwan, et al.
Publicado: (2014)

Clinical Efficacy of Allergen-Specific Immunotherapy from Patient and Physician Perspectives
por: Shin, Yoo Seob, et al.
Publicado: (2019)

Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
por: Zhuang, Jia, et al.
Publicado: (2019)

Antioxidant and Antibacterial Properties of Hovenia (Hovenia dulcis) Monofloral Honey Produced in South Korea
por: Park, Seung Hee, et al.
Publicado: (2020)

Protein-Based Nanoparticles as Drug Delivery Systems
por: Hong, Seyoung, et al.
Publicado: (2020)

Lipid Nanoparticles for Enhancing the Physicochemical Stability and Topical Skin Delivery of Orobol
por: Kim, Min-Hwan, et al.
Publicado: (2020)

The Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency
por: Noh, Kyung Tae, et al.
Publicado: (2012)

Liver-specific Gene Delivery Using Engineered Virus-Like Particles of Hepatitis E Virus
por: Lee, Eun Byul, et al.
Publicado: (2019)

Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma
por: Wi, Tae In, et al.
Publicado: (2020)

Heat shock protein X purified from Mycobacterium tuberculosis enhances the efficacy of dendritic cells-based immunotherapy for the treatment of allergic asthma
por: Kim, Hye-young, et al.
Publicado: (2015)

Nanoparticles for Lymph Node-Directed Delivery
por: Lee, Jaeseong, et al.
Publicado: (2023)

Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy
por: Nam, Jutaek, et al.
Publicado: (2021)

Efficacy and Safety of Sublingual Immunotherapy in Elderly Rhinitis Patients Sensitized to House Dust Mites
por: Kim, Ji Hye, et al.
Publicado: (2018)

Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis
por: Lee, So-Hee, et al.
Publicado: (2019)

Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
por: Han, Jieun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v5u5c002jr8tqncdkl02gltk89